Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma × Telemedicine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 7 Colorectal Neoplasms 4 Lung Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Prostatic Neoplasms 2 Pain 2 Motor Activity 2 Hematopoietic and Lymphatic System Neoplasm 2 Carcinoma, Non-Small-Cell Lung 2 Breast Carcinoma In Situ 2 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Sedentary Behavior 1 Sarcoma 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Pulmonary Disease, Chronic Obstructive 1 Polyps 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Metastatic Pancreatic Adenocarcinoma 1 Malignant Hepatobiliary Neoplasm 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Head and Neck Neoplasms 1

Interventions

Oxaliplatin 42 Gemcitabine 41 Fluorouracil 37 pembrolizumab 29 Capecitabine 29 Leucovorin 26 Docetaxel 25 Cisplatin 24 Paclitaxel 21 Carboplatin 18 Bevacizumab 17 Irinotecan 16 130-nm albumin-bound paclitaxel 16 Radiotherapy 15 Pemetrexed 15 Nivolumab 13 Albumin-Bound Paclitaxel 13 Cyclophosphamide 10 Ramucirumab 9 zolbetuximab 7 Trastuzumab 7 Radiosurgery 7 Drug Therapy 7 trastuzumab deruxtecan 6 cemiplimab 6 Taxes 6 Erlotinib Hydrochloride 6 Blood Specimen Collection 6 durvalumab 5 Sorafenib 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04667403 2022-04-28

PANTELO

Institut Cancerologie de l'Ouest

Phase NA Unknown

Adenocarcinoma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡